Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Merck CEO: China Will Have a Top 50 Biopharma Company

publication date: Jan 23, 2019

"Right now, there is no Chinese company among the top 50 in the biopharmaceutical industry, but I'm absolutely certain that this is going to change," said German Merck's Chair and CEO, Stefan Oschmann, PhD. Dr. Oschmann was speaking to CNBC reporters at the Davos Conference (see story). He also believes that China, like the US and Israel, has a working ecosystem for biopharma innovation -- a strong collaboration between the military, academic centers, and private/public drug companies. Europe does not have this ecosystem, he added. More details....

Stock Symbol: (Xetra: MRK)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital